Evidence map›Paper›PMID 38760692›Full record

ArticleBMC bioinformatics2024

Semi-quantitative group testing for efficient and accurate qPCR screening of pathogens with a wide range of loads.

Ananthan Nambiar, Chao Pan, Vishal Rana, Mahdi Cheraghchi, João Ribeiro, Sergei Maslov, Olgica Milenkovic

Abstract read
In one paragraph

Article in BMC bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ananthan Nambiar *Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, IL, USA. nambiar4@illinois.edu.
Chao Pan *Department of Electrical and Computer Engineering, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Vishal Rana *Department of Electrical and Computer Engineering, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Mahdi CheraghchiDepartment of Electrical Engineering and Computer Science, University of Michigan, Ann Arbor, MI, USA.
João RibeiroNOVA LINCS and NOVA School of Science and Technology, Caparica, Portugal.
Sergei MaslovDepartment of Bioengineering, University of Illinois Urbana-Champaign, Urbana, IL, USA. maslov@illinois.edu.
Olgica MilenkovicDepartment of Electrical and Computer Engineering, University of Illinois Urbana-Champaign, Urbana, IL, USA. milenkovic@illinois.edu.

Funding

Division of Computing and Communication Foundations 2107344Division of Computing and Communication Foundations 2107345
6 · The paper itself

Abstract

backgroundPathogenic infections pose a significant threat to global health, affecting millions of people every year and presenting substantial challenges to healthcare systems worldwide. Efficient and timely testing plays a critical role in disease control and transmission prevention. Group testing is a well-established method for reducing the number of tests needed to screen large populations when the disease prevalence is low. However, it does not fully utilize the quantitative information provided by qPCR methods, nor is it able to accommodate a wide range of pathogen loads.

resultsTo address these issues, we introduce a novel adaptive semi-quantitative group testing (SQGT) scheme to efficiently screen populations via two-stage qPCR testing. The SQGT method quantizes cycle threshold (Ct) values into multiple bins, leveraging the information from the first stage of screening to improve the detection sensitivity. Dynamic Ct threshold adjustments mitigate dilution effects and enhance test accuracy. Comparisons with traditional binary outcome GT methods show that SQGT reduces the number of tests by 24% on the only complete real-world qPCR group testing dataset from Israel, while maintaining a negligible false negative rate.

conclusionIn conclusion, our adaptive SQGT approach, utilizing qPCR data and dynamic threshold adjustments, offers a promising solution for efficient population screening. With a reduction in the number of tests and minimal false negatives, SQGT holds potential to enhance disease control and testing strategies on a global scale.

Indexed as

Real-Time Polymerase Chain ReactionHumansCOVID-19Ct valuesGroup testingPooled testingqPCRSemiquantitative group testingViral load

Identifiers

PMID38760692
PMCPMC11100062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.